These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Nevada
|
20-2781289
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
Bath House
|
|
|
8 Chapel Place
|
|
|
London, Great Britain
|
EC2A 3DQ
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
¨
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
x
|
|
•
|
our ability to raise capital to finance our growth, operations and general working capital needs, when needed and on terms advantageous to us;
|
|
•
|
our ability to manage growth, profitability and the marketability of our products and services;
|
|
•
|
general economic and business conditions;
|
|
•
|
the effect on our business of recent credit-tightening throughout the world;
|
|
•
|
the impact of developments and competition within the fossil fuels and alternative energy industries;
|
|
•
|
adverse results of any legal proceedings;
|
|
•
|
the impact of current, pending or future legislation and regulation on the fossil fuels and alternative energy industries, including, but not limited to, changes in zoning and environmental laws and regulations;
|
|
•
|
our ability to maintain and enter into relationships with suppliers, vendors or contractors of acceptable quality of goods and services on terms advantageous to us;
|
|
•
|
changes in foreign currency exchange rates;
|
|
•
|
political and government changes in the countries (including local and regional governments) in which we operate;
|
|
•
|
the volatility of our operating results and financial condition;
|
|
•
|
our ability to attract and retain qualified senior management personnel; and
|
|
•
|
the other risks and uncertainties detailed in this Form 10-Q and, from time to time, in our other filings with the Securities and Exchange Commission.
|
|
Item 1.
|
Financial Statements.
|
|
January 31, 2011
|
October 31, 2010
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash
|
$ | 114,393 | $ | 392,502 | ||||
|
Accounts receivable
|
631,977 | - | ||||||
|
Prepaid expenses and other
|
2,139,245 | 1,853,952 | ||||||
|
Total current assets
|
2,885,615 | 2,246,454 | ||||||
|
Fixed Assets
|
||||||||
|
Property and equipment, net
|
22,899 | 21,450 | ||||||
|
Total fixed assets
|
22,899 | 21,450 | ||||||
|
Other Assets
|
||||||||
|
Deposits
|
230,634 | 143,020 | ||||||
|
Total other assets
|
230,634 | 143,020 | ||||||
|
TOTAL ASSETS
|
$ | 3,139,148 | $ | 2,410,924 | ||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIENCY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 2,864,360 | $ | 1,767,689 | ||||
|
Payroll liabilities
|
87,407 | 28,432 | ||||||
|
Due to affiliates and stockholders
|
4,025,927 | 3,491,032 | ||||||
|
Total current liabilities
|
6,977,694 | 5,287,153 | ||||||
|
Total liabilities
|
6,977,694 | 5,287,153 | ||||||
|
Stockholders' Deficiency
|
||||||||
|
Preferred stock, $0.001 par value; authorized: 10,000,000; issued: none
|
- | - | ||||||
|
Common stock, $0.001 par value; 500,000,000 shares authorized; issued: 142,428,834 and 141,755,788 shares, respectively
|
142,429 | 141,756 | ||||||
|
Additional paid in capital
|
37,005,360 | 36,763,163 | ||||||
|
Stock subscription receivable
|
(37,855 | ) | (181,215 | |||||
|
Accumulated other comprehensive income
|
214,026 | 217,800 | ||||||
|
Accumulated deficit
|
(41,162,506 | ) | (39,817,733 | ) | ||||
|
Total stockholders' deficiency
|
(3,838,546 | ) | (2,876,229 | ) | ||||
|
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
|
$ | 3,139,148 | $ | 2,410,924 | ||||
|
Three Months Ended
|
From
|
|||||||||||
|
January 31,
|
Inception to
|
|||||||||||
|
2011
|
2010
|
January 31, 2011
|
||||||||||
|
Revenue
|
$ | 1,897,842 | $ | - | $ | 2,114,840 | ||||||
|
Cost of services
|
1,598,081 | - | 1,930,388 | |||||||||
|
Gross profit
|
299,761 | - | 184,452 | |||||||||
|
General and administrative expenses
|
792,725 | 1,449,598 | 37,504,020 | |||||||||
|
Research and development
|
5,025 | 10,133 | 2,365,870 | |||||||||
|
Operating loss
|
(497,989 | ) | (1,459,731 | ) | (39,685,438 | ) | ||||||
|
Interest expense
|
846,785 | - | 1,478,574 | |||||||||
|
Other expenses
|
- | - | 8,275 | |||||||||
|
Other income
|
- | - | (9,781 | ) | ||||||||
|
Loss before income taxes
|
(1,344,773 | ) | (1,459,731 | ) | (41,162,506 | ) | ||||||
|
Provision for income taxes
|
||||||||||||
|
Federal
|
- | - | - | |||||||||
|
State
|
- | - | - | |||||||||
|
Net loss
|
$ | (1,344,773 | ) | $ | (1,459,731 | ) | $ | (41,162,506 | ) | |||
|
Loss per share, basic and diluted
|
$ | (0.01 | ) | $ | (0.02 | ) | $ | (0.29 | ) | |||
|
Weighted average common shares outstanding
|
142,046,368 | 90,305,470 | 142,046,368 | |||||||||
|
Comprehensive loss:
|
||||||||||||
|
Net loss
|
$ | (1,344,773 | ) | $ | (1,459,731 | ) | $ | (41,162,506 | ) | |||
|
Foreign currency translation income/(loss)
|
(3,774 | ) | (34,712 | ) | 214,026 | |||||||
|
Comprehensive loss
|
$ | (1,348,547 | ) | $ | (1,494,443 | ) | $ | (40,948,480 | ) | |||
|
Three Months Ended
|
From
|
|||||||||||
|
January 31,
|
Inception to
|
|||||||||||
|
2011
|
2010
|
January 31, 2011
|
||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||
|
Net loss
|
$ | (1,344,773 | ) | $ | (1,459,731 | ) | $ | (41,162,506 | ) | |||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
|
Adjustments for charges not requiring outlay of cash
:
|
||||||||||||
|
Deferred financing costs
|
297,733 | - | 956,172 | |||||||||
|
Depreciation and amortization
|
1,997 | 1,326 | 9,303 | |||||||||
|
Common stock issued for interest
|
- | - | 228,100 | |||||||||
|
Common stock issued for compensation
|
- | 533,125 | 28,937,623 | |||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
(Increase)/decrease prepaid expenses and other current assets
|
(296,260 | ) | (265,387 | ) | (358,255 | ) | ||||||
|
(Increase)/decrease accounts receivable
|
(631,977 | ) | - | (631,977 | ) | |||||||
|
Deposits
|
(87,614 | ) | (16,722 | ) | (140,634 | ) | ||||||
|
Increase/(decrease) in accounts payable and accrued expenses
|
809,906 | 125,015 | 2,374,360 | |||||||||
|
Increase/(decrease) in accrued payroll liabilities
|
58,975 | 19,361 | 87,407 | |||||||||
|
Total adjustments to net loss
|
152,760 | 396,718 | 31,462,099 | |||||||||
|
Net cash used in operating activities
|
(1,192,013 | ) | (1,063,013 | ) | (9,700,407 | ) | ||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||||||
|
UBF advances
|
- | - | (1,791,957 | ) | ||||||||
|
Purchase of furniture and equipment
|
(3,446 | ) | (6,290 | ) | (32,202 | ) | ||||||
|
Net cash flows used in investing activities
|
(3,446 | ) | (6,290 | ) | (1,824,159 | ) | ||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||||||
|
Cash received from sale of stock
|
386,229 | 1,472,822 | 2,578,378 | |||||||||
|
Due to affiliates and stockholders, net
|
534,895 | - | 7,512,416 | |||||||||
|
Cash received on notes payable
|
- | - | 1,334,139 | |||||||||
|
Net cash provided by financing activities
|
921,124 | 1,472,822 | 11,424,933 | |||||||||
|
CASH RECONCILIATION:
|
||||||||||||
|
Effect of exchange rate changes on cash
|
(3,774 | ) | (34,712 | ) | 214,026 | |||||||
|
Net increase (decrease) in cash and cash equivalents
|
(278,109 | ) | 368,807 | 114,393 | ||||||||
|
Cash and cash equivalents - beginning balance
|
392,502 | 1,472 | - | |||||||||
|
CASH AND CASH EQUIVALENTS BALANCE END OF PERIOD
|
$ | 114,393 | $ | 370,279 | $ | 114,393 | ||||||
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
|
||||||||||||
|
Common stock issued for deposit on asset
|
$ | - | $ | - | $ | 90,000 | ||||||
|
Common stock issued for debt cancellation
|
$ | - | $ | - | $ | 4,356,725 | ||||||
|
Common stock issued in recapitalization
|
$ | - | $ | - | $ | 2,175 | ||||||
|
Cash paid for interest
|
$ | - | $ | - | $ | 254,435 | ||||||
|
NOTE 1.
|
ORGANIZATION AND DESCRIPTION OF BUSINESS
|
|
NOTE 2.
|
BASIS OF PRESENTATION
|
|
NOTE 3.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
|
NOTE 4.
|
GOING CONCERN
|
|
NOTE 5.
|
PREPAID EXPENSES AND OTHER
|
|
NOTE 6.
|
STOCK TRANSACTIONS
|
|
NOTE 7.
|
NOTE PAYABLE
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations.
|
|
Operating Expenses
|
$ | 4,540,000 | ||
|
Management and Consulting
|
1,210,000 | |||
|
General and Administrative
|
950,000 | |||
|
Total
|
$ | 6,700,000 |
|
Item 1.
|
Legal Proceedings.
|
|
Item 1A.
|
Risk Factors.
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
|
Item 3.
|
Defaults upon Senior Securities.
|
|
Item 4.
|
(Removed and Reserved).
|
|
Item 5.
|
Other Information.
|
|
Item 6.
|
Exhibits.
|
|
Exhibit
|
||
|
Number
|
Exhibit Description
|
|
|
10.1
|
Promissory Note of Clenergen Corporation dated Febuary 16, 2011 in the amount of $177,884 and payable to Mastreta Advisors Corp.
|
|
|
10.2
|
Amended Exclusive License Agreement, dated March 9, 2011, between Clenergen Corporation and BioPower Corporation.
|
|
|
31.1
|
Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.
|
|
|
32.1
|
Section 1350 Certification of Principal Executive Officer.
|
|
|
32.2
|
|
Section 1350 Certification of Principal Financial Officer.
|
|
Dated: March 22, 2011
|
Clenergen Corporation
|
|
|
By:
|
/s/ Mark L.M. Quinn
|
|
|
Mark L.M. Quinn
|
||
|
Executive Chairman of the Board
|
||
|
(Duly Authorized Officer
|
||
|
and Principal Executive Officer)
|
||
|
By:
|
/s/ Mike Starkie
|
|
|
Mike Starkie
|
||
|
Acting Chief Financial Officer
|
||
|
(Principal Financial and Accounting Officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|